Use access key #2 to skip to page content.
$0.24 0.00 (0.00%)
9/16/2008 3:24 PM

Zila, Inc. (ZILA)

CAPS Rating:
No stars

The Company is a specialty pharmaceutical company focused on the prevention and treatment of oral cancer.

View All Commentary (ZILA)

Recs

0

Avatar 1poorguy (95.17) Submitted: 9/14/06 10:26 PM : Underperform Start Price: $2.62 ZILA Score: 57.67

Has some good products including toludine blue rinse, EsterC, and Zilactin. But their results remain unexciting, and the stock languishes in obscurity.

Report this Post Replies: 0 | Reply

Featured Broker Partners